IRIS UniCatt

Pagano, Livio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.707
EU - Europa 9.799
AS - Asia 9.175
SA - Sud America 2.107
AF - Africa 254
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 9
Totale 32.071
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.395
SG - Singapore 4.333
DE - Germania 3.579
CN - Cina 2.545
BR - Brasile 1.753
SE - Svezia 1.529
IT - Italia 1.061
UA - Ucraina 837
FR - Francia 591
IE - Irlanda 523
IN - India 453
GB - Regno Unito 424
VN - Vietnam 377
ID - Indonesia 357
RU - Federazione Russa 296
FI - Finlandia 284
PL - Polonia 228
TR - Turchia 160
IQ - Iraq 136
HK - Hong Kong 129
MX - Messico 125
CA - Canada 123
AR - Argentina 121
BD - Bangladesh 120
JP - Giappone 96
NL - Olanda 89
KR - Corea 77
ES - Italia 69
AT - Austria 66
ZA - Sudafrica 66
PK - Pakistan 57
EC - Ecuador 54
SA - Arabia Saudita 49
BE - Belgio 43
EG - Egitto 40
VE - Venezuela 40
CL - Cile 36
JO - Giordania 34
CO - Colombia 33
MA - Marocco 32
IL - Israele 29
KE - Kenya 29
UZ - Uzbekistan 28
CZ - Repubblica Ceca 25
CI - Costa d'Avorio 24
LT - Lituania 23
PY - Paraguay 23
AE - Emirati Arabi Uniti 22
KZ - Kazakistan 22
RO - Romania 21
AU - Australia 17
CH - Svizzera 17
PE - Perù 17
AZ - Azerbaigian 15
UY - Uruguay 15
PH - Filippine 14
NP - Nepal 13
TH - Thailandia 13
BO - Bolivia 12
IR - Iran 12
JM - Giamaica 12
AL - Albania 11
DZ - Algeria 11
MD - Moldavia 11
CR - Costa Rica 10
ET - Etiopia 10
HU - Ungheria 10
TN - Tunisia 10
AM - Armenia 9
GR - Grecia 9
NG - Nigeria 9
BH - Bahrain 8
DO - Repubblica Dominicana 8
MY - Malesia 8
OM - Oman 8
PS - Palestinian Territory 8
DK - Danimarca 7
EU - Europa 7
LV - Lettonia 7
PA - Panama 7
HN - Honduras 6
BG - Bulgaria 5
GE - Georgia 5
HR - Croazia 5
LA - Repubblica Popolare Democratica del Laos 5
NO - Norvegia 5
SN - Senegal 5
GT - Guatemala 4
LK - Sri Lanka 4
NI - Nicaragua 4
QA - Qatar 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BY - Bielorussia 3
GH - Ghana 3
IS - Islanda 3
KG - Kirghizistan 3
LB - Libano 3
LY - Libia 3
Totale 32.010
Salva come PNG Salva come JPEG
Città #
Singapore 1.807
Chandler 1.635
Ashburn 1.024
Jacksonville 532
Dublin 513
Beijing 432
San Mateo 403
Jakarta 334
Ann Arbor 312
Hefei 306
Wilmington 286
Nanjing 278
New York 278
Los Angeles 269
Frankfurt am Main 254
Dearborn 219
Milan 212
Boston 205
Munich 202
Houston 196
Hyderabad 189
Chicago 187
Nürnberg 186
Warsaw 186
Moscow 183
Woodbridge 183
Lawrence 170
São Paulo 163
Bremen 158
Hangzhou 155
Rome 151
Ho Chi Minh City 145
Cattolica 129
Dallas 124
Hong Kong 123
Buffalo 118
Zhengzhou 117
Princeton 103
Hanoi 96
Nanchang 91
Seattle 90
Redwood City 88
Marseille 87
Kent 81
Izmir 80
Fairfield 78
Seoul 75
Boardman 69
Redmond 69
Nuremberg 66
Tokyo 63
Rio de Janeiro 61
Mountain View 60
Shenyang 60
Hebei 58
Tianjin 58
Kunming 52
Santa Clara 52
Shanghai 51
Lancaster 50
Brooklyn 48
Baghdad 47
Norwalk 45
Changsha 44
University Park 43
Brussels 41
The Dalles 41
Toronto 41
Belo Horizonte 40
Jiaxing 38
Washington 37
Guangzhou 36
Helsinki 36
Mexico City 36
Philadelphia 36
Leawood 35
London 35
Orem 35
Phoenix 34
Amman 33
Cambridge 32
Dhaka 31
Poplar 31
Turku 31
Düsseldorf 30
Paris 30
San Francisco 30
Lappeenranta 29
Porto Alegre 29
Chennai 28
Montreal 28
Salt Lake City 28
Brasília 27
Henderson 27
Johannesburg 27
Vienna 27
Denver 26
Nairobi 26
Pune 26
Atlanta 25
Totale 15.351
Salva come PNG Salva come JPEG
Nome #
5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature 406
Incidence of acute myeloid leukemia after breast cancer 363
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 350
Factors associated with mortality in bacteremic patients with hematologic malignancies. 345
Factors associated with mortality in bacteremic patients with haematologic malignancies 337
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 334
A prospective survey of febrile events in hematological malignancies 289
Therapy-related leukemias and myelodysplasia : susceptibility and incidence. 256
A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature 247
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study 212
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 205
Factors associated with mortality in bacteremic patients with hematologic malignancies. 205
Systemic granulomatous reaction secondary to treatment of bladder cancer with Bacillus Calmette-Guerin 202
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 191
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia. 187
Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay 181
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 174
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. 174
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 174
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 170
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 166
Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases 161
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 159
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 159
Impaired bactericidal and fungicidal activities of neutrophils in patients with myelodysplastic syndrome 158
Epigenetic changes in therapy-related MDS/AML 157
Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect 154
Similarities and differences between therapy-related and elderly acute myeloid leukemia 152
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 149
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 148
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 147
Primary plasma cell leukemia followed by testicular plasmacytoma 146
Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 144
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 144
All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients 144
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 143
Serum beta 2 microglobulin in psoriasis and psoriatic patients 143
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 143
Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency 143
Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto SCTsuccessfully treated with combination treatment. 140
Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report 139
Hyperleukocytosis and leukostasis: management of a medical emergency 138
Adjuvant therapy with rhGM-CSF for the treatment of Blastoschizomyces capitatus systemic infection in a patient with acute myeloid leukemia 137
A prospective survey of febrile events in hematological malignancies 137
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 135
Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol. 132
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry 132
Hyperleukocytosis and leukostasis: management of a medical emergency 132
A prospective survey of febrile events in hematological malignancies 131
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 130
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 130
Hema e-Chart: Italian Registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies 129
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 129
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 129
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 128
Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry 128
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 128
Advanced mast cell disease: an Italian Hematological Multicenter experience. 127
Immature platelet fraction (IPF) in hospitalized patients with neutrophilia and suspected bacterial infection 127
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 127
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 127
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients 127
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 126
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 126
Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016-B survey 126
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias 125
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 124
Tunneling Schmorl?s Nodes in an Elderly Woman Treated for Acute Lymphoblastic Leukemia. 123
A patient with acute myeloid leukemia and a solid mass in the colon. 123
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study 121
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 121
Uncommon yeast infections in hematological patients: from diagnosis to treatment 120
Outcome of therapy-related myeloid neoplasms treated with azacitidine 120
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients 119
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey 119
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project 117
Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party 117
SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disorders 116
Scedosporiosis in patients with acute leukemia: a retrospective multicenter report 115
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations 115
First case of breakthrough pneumonia due to Aspergillus nomius in a patient with acute myeloid leukemia 114
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) 113
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 112
High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma. 111
Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report. 110
In vitro susceptibility of Candida species isolated from patients with haematological malignancies 110
Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107) 109
Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule 109
Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches 109
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 109
Caspofungin for the treatment of candidaemia in patients with haematological malignancies 107
ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients 107
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 107
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 107
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project 105
Developments in identifying and managing mucormycosis in hematologic cancer patients 105
Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis 105
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 104
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 103
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry 102
Totale 15.212
Salva come PNG Salva come JPEG
Categoria #
all - tutte 144.041
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 144.041
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.091 0 0 0 0 0 125 247 52 220 72 348 27
2021/20222.205 260 151 34 88 149 76 33 334 115 156 332 477
2022/20234.610 525 562 397 773 365 588 167 373 561 94 158 47
2023/20242.512 126 738 92 81 95 351 203 51 36 91 302 346
2024/20255.995 168 166 398 190 445 150 228 265 960 651 1.360 1.014
2025/20268.014 2.189 373 866 1.469 2.359 758 0 0 0 0 0 0
Totale 32.433